NCT01489813 2025-02-05
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Emory University
Phase 2 Completed
Clinical Trials
12 trialsNCT02624388 2024-05-06
UVA-Gen001
University of Virginia
Phase 2 Terminated
NCT00244933 2023-06-22
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT02766478 2022-09-27
GeniPro
Emory University
Phase 2 Terminated
NCT00118040 2021-06-10
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00376948 2021-03-01
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00882765 2020-07-31
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT01126879 2019-09-10
Genistein in Treating Patients With Prostate Cancer
Northwestern University
Phase 2 Terminated
NCT00290758 2017-02-08
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01325311 2016-08-03
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00058266 2012-07-19
Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy
Northwestern University
Phase 2 Terminated
NCT00546039 2008-09-30
Synthetic Genistein (BONISTEINâ„¢) in Patients Who Are Undergoing Surgery for Prostate Cancer
University Hospital, Aker
Phase 2 Unknown